DM
Dineshkumar M Prajapati
About Dineshkumar M Prajapati
Data last updated:
Dineshkumar M Prajapati is a Director at Aestimare Lifescience Private Limited (since 2023) and Director at Attwell Pharmaceuticals Private Limited (since 2025). The companies operate in Events and Entertainment and Pharma. The largest current company by reported revenue is Aestimare Lifescience Private Limited at ₹39.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jun 2023 | 2020 | ₹39.1 Lakh (FY 2025) | Active | |
| Director | 31 Jan 2025 | 2025 | Active |
Board colleagues of Dineshkumar M Prajapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Durgesh Manglaprasad Mishra | 07295599 | Aestimare Lifescience Private Limited , Attwell Pharmaceuticals Private Limited | Additional Director |
| Shashank Bhooshan Upadhyay | 08991467 | Aestimare Lifescience Private Limited | Director |
| Sannu Kumar Gupta | 11255698 | Attwell Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dineshkumar M Prajapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dineshkumar M Prajapati
Dineshkumar M Prajapati currently holds 2 directorships: Aestimare Lifescience Private Limited (Director, since 29 Jun 2023, revenue ₹39.1 Lakh (FY 2025)); Attwell Pharmaceuticals Private Limited (Director, since 31 Jan 2025).
Dineshkumar M Prajapati was first appointed on 29 Jun 2023 as Director at Aestimare Lifescience Private Limited. The most recent appointment on record is 31 Jan 2025 at Attwell Pharmaceuticals Private Limited.
The current boards of Dineshkumar M Prajapati's companies include Durgesh Manglaprasad Mishra (Aestimare Lifescience Private Limited), Shashank Bhooshan Upadhyay (Aestimare Lifescience Private Limited), Sannu Kumar Gupta (Attwell Pharmaceuticals Private Limited).